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The function of the urinary bladder is partly controlled by parasympathetic preganglionic
neurons (PPNs) of the sacral parasympathetic nucleus (SPN). Our recent work
demonstrated that endomorphin-2 (EM-2)-immunoreactive (IR) terminals form synapses
with µ-opioid receptor (MOR)-expressing PPNs in the rat SPN. Here, we examined the
effects of EM-2 on excitatory synaptic transmission and the neuronal excitability of the
PPNs in young rats (24–30 days old) using a whole-cell patch-clamp approach. PPNs
were identified by retrograde labeling with the fluorescent tracer tetramethylrhodamine-
dextran (TMR). EM-2 (3 µM) markedly decreased both the amplitude and the frequency
of the spontaneous and miniature excitatory postsynaptic currents (sEPSCs and
mEPSCs) of PPNs. EM-2 not only decreased the resting membrane potentials (RMPs)
in 61.1% of the examined PPNs with half-maximal response at the concentration of
0.282 µM, but also increased the rheobase current and reduced the repetitive action
potential firing of PPNs. Analysis of the current–voltage relationship revealed that the
EM-2-induced current was reversed at −95 ± 2.5 mV and was suppressed by perfusion
of the potassium channel blockers 4-aminopyridine (4-AP) or BaCl2 or by the addition
of guanosine 5′-[β-thio]diphosphate trilithium salt (GDP-β-S) to the pipette solution,
suggesting the involvement of the G-protein-coupled inwardly rectifying potassium
(GIRK) channel. The above EM-2-invoked inhibitory effects were abolished by the MOR
selective antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), indicating that
the effects of EM-2 on PPNs were mediated by MOR via pre- and/or post-synaptic
mechanisms. EM-2 activated pre- and post-synaptic MORs, inhibiting excitatory
neurotransmitter release from the presynaptic terminals and decreasing the excitability
of PPNs due to hyperpolarization of their membrane potentials, respectively. These
inhibitory effects of EM-2 on PPNs at the spinal cord level may explain the mechanism
of action of morphine treatment and morphine-induced bladder dysfunction in the clinic.
Keywords: endomorphin-2, parasympathetic preganglionic neurons, sacral parasympathetic nucleus, neuronal
excitability, spontaneous excitatory postsynaptic current, urinary retention
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Introduction
Morphine is an exogenous ligand of the µ-opioid receptor
(MOR) and is the only FDA-approved opioid for intrathecal
administration. Morphine is effective, inexpensive, and well
tolerated by the majority of patients (Winkelmüller and
Winkelmüller, 1996; Ruan, 2007). However, the clinically
relevant side effects of the intrathecal administration of
morphine, including urinary retention, have largely limited
its clinical application (Ruan, 2007). Although morphine
can inhibit bladder activity when it is administered into
cervical, thoracic or lumbar regions, this inhibitory effect
is faster acting and more effective when it is administered
directly in the vicinity of the lumbosacral spinal cord (Dray
and Metsch, 1984a). Additionally, urinary retention has
not been reported following intraventricular morphine
administration (Ruan, 2007). Moreover, the detrusor
relaxation caused by epidural morphine in humans is
readily reversed with naloxone (Rawal et al., 1983). All
of these results indicate that morphine, the exogenous
ligand of MOR, is involved in the neurogenic inhibition of
bladder motility via spinal mechanisms (Dray and Metsch,
1984a,b).
Previous studies have revealed that the sacral parasympathetic
nucleus (SPN), which is located in the intermediolateral region
of the caudal lumbar and rostral sacral (L6-S1) spinal segments
in the rat (Nadelhaft and Booth, 1984; Nadelhaft and Vera,
1995; Miura et al., 2000, 2001, 2003; Vera and Nadelhaft, 2000;
Dou et al., 2013), is a spinal autonomic nervous center that
controls various functions of pelvic organs includingmicturition,
defecation and penile erection (Fowler et al., 2008; de Groat
et al., 2015). The parasympathetic preganglionic neurons (PPNs)
of the SPN play a critical role in regulating these functions
(Grill et al., 1999; Tai et al., 2004). Morphological studies
have demonstrated that MOR-immunoreactive (IR) neurons are
widely distributed in the spinal cord, including in the SPN
(Gouardères et al., 1991; Mansour et al., 1994; Ding et al.,
1996). The processes of PPNs are distributed extensively in
the spinal cord, including in the dorsal commissural nucleus
(DCN) in the superficial layers of the dorsal horn (Nadelhaft
et al., 1980; Nadelhaft and Booth, 1984; Morgan et al., 1993),
where they are immunopositive for MOR. Endomorphins,
including endomorphin-1 (EM-1) and endomorphin-2 (EM-2),
have high affinity and selectivity for MOR and are considered
its endogenous ligands (Hackler et al., 1997; Zadina et al.,
1997). Additionally, endogenous opioids have been suggested
to play a critical role in the control of bladder function via
the modulation of the parasympathetic outflow at the sacral
cord level (Drenger et al., 1986). Our recent study revealed
that EM-2-IR terminals form synapses with MOR-expressing
PPNs in the rat SPN (Dou et al., 2013). To investigate
the functional significance of these morphological results, we
examined the effects of EM-2 on excitatory synaptic transmission
and the neuronal excitability of PPNs in young rats (24–30
days old) using whole-cell patch-clamp recording. PPNs were
identified by retrograde tracing with tetramethylrhodamine-
dextran (TMR).
Experimental Procedures
Animals
Male Sprague Dawley (SD) rats aged 21–24 days were provided
by the Experimental Animal Center of the Fourth Military
Medical University (Xi’an, China). Rats were housed on a 12-
h light–dark cycle (8 a.m. to 8 p.m. light) with access to food
and water ad libitum. All animal experiments were approved by
the Institutional Animal Care and Use Committee of the Fourth
Military Medical University. All efforts were made to reduce the
number of animals used and to minimize their suffering.
Retrograde Labeling of PPNs
Parasympathetic preganglionic neurons (PPNs) in the sacral
spinal cord were identified by retrograde labeling with TMR
(3000 MW, Molecular Probe, Eugene, OR, USA). The procedure
for the retrograde labeling operation was conducted according
to that described in our previous works (Dou et al., 2013).
For this purpose, the rats were anesthetized with a 2% sodium
pentobarbital solution (40 mg/kg, i.p.), and the right pelvic nerve
of each rat was exposed via a posterior approach through the
sacrococcygeal region. After the dissection of the pelvic nerve,
1 µl of 10% TMR distilled in 0.1 M citrate-NaOH (pH 3; Kaneko
et al., 1996) was applied to the surface of the nerve with a
microsyringe.
Slice Preparation
After the retrograde tracing operation, the rats were allowed to
survive for 3–6 days. The rats were then anesthetized with 2%
sodium pentobarbital (80 mg/kg, i.p.). After the disappearance
of reflexes, the rats were perfused transcardially for 1 min with
100 ml of 2–4◦C sucrose artificial cerebrospinal fluid (sucrose-
aCSF) in which the NaCl had been replaced with sucrose (Mitra
and Brownstone, 2012; Lu et al., 2013) and containing the
following reagents (in mM): 220 sucrose, 2.5 KCl, 26 NaHCO3,
6.0 MgSO4, 1.2 KH2PO4, 0.5 CaCl2, 10 glucose, 1 ascorbate,
and 3 sodium pyruvate. All aCSF solutions were bubbled with
carbogen gas (95% O2 and 5% CO2). The spinal cord at L6-
S1 was removed using pressurized sucrose-aCSF with a 2-ml
syringe. Transverse slices (300 µm thick) were cut on a vibrating
microtome (Leica VT 1200s, Heidelberger, Nussloch, Germany)
in 2–4◦C sucrose-aCSF bubbled with carbogen gas. The slices
were transferred to an incubation chamber filled with normal-
sodium aCSF (normal-aCSF) that was continuously bubbled with
carbogen gas and incubated at room temperature (22–24◦C). The
normal-aCSF consisted of the following reagents (in mM): 124
NaCl, 2.5 KCl, 25 NaHCO3, 2 MgSO4, 1 NaH2PO4, 2 CaCl2, 10
glucose, 1 ascorbate, and 3 sodium pyruvate.
Whole Cell Patch Clamp Recording
After a 1 h recovery period, the slices were transferred to
recording chambers (volume 0.5 ml) mounted on a fixed-stage
upright microscope (BX51W1, Olympus, Tokyo, Japan). The
slices were continuously perfused with normal-aCSF bubbled
with carbogen gas at a rate of 2–3 ml/min. The experiments
were performed at 30 ± 1◦C using a heat controller. The patch
pipettes were constructed with a P-97 micropipette puller (Sutter
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Instruments, Novato, CA, USA) from borosilicate glass capillary
tubes (World Precision Instruments, Sarasota, FL, USA). The
tip resistances were in the range of 2–6 MΩ when filled with
the pipette solution, which contained the following reagents
(in mM): 130 potassium gluconate, 15 KCl, 5 NaCl, 10 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 4 Mg-
ATP, 0.3 Na2-GTP, and 0.4 ethylene glycol tetraacetic acid
(EGTA). This solution was titrated to pH 7.3 with KOH. The
osmolality of the pipette solutions was adjusted to 290–300
mOsm. To visualize the recorded neurons, 0.2% biocytin (Sigma-
Aldrich, St. Louis, MO, USA) was added to the recording
pipette solution. Whole cell patch-clamp recordings were
performed on TMR-containing PPNs that were visualized under
epifluorescence using a tetramethyl rhodamine isothiocyanate
(TRITC) filter set (U-HGLGPS, Olympus) with a monochrome
CCD camera (IR-1000E, DAGE-MTI, Michigan, USA) and
monitor. The neurons were recorded using a Multiclamp 700B
amplifier (Axon Instruments, Foster City, CA, USA). pCLAMP
software (v. 10.02, Axon Instruments) was used to acquire
and analyze the data. The signals were filtered at 2.6 kHz,
digitized at 10 kHz (Digidata 1322A, Axon Instruments), and
saved on a computer for offline analysis. Recordings that
met the following criteria were included in the analyses: a
resting membrane potential of at least −45 mV (the liquid
junction potential was not corrected and was 13.7 mV in
our experimental conditions), and a series resistance (Rs) was
≤30 MΩ. Average Rs did not change by more than 10%
in any of the accepted recordings. A separate template was
created for each recording by averaging a large number of
hand-selected unambiguous spontaneous excitatory postsynaptic
currents (sEPSCs) or miniature excitatory postsynaptic currents
(mEPSCs).
Immunohistochemical Staining for TMR, MOR
and Biocytin
After recording, the slices were fixed in 4% paraformaldehyde in
0.1 M phosphate buffer (pH 7.4) for 4 h and were subsequently
stored in 30% sucrose solution overnight at 4◦C. After three
rinses with 0.01 M PBS, the slices were processed for TMR, MOR
and biocytin immunofluorescent staining. The sections were
subjected to the following series of incubations. (1) The sections
were incubated with a mixture of rabbit antiserum against TMR
(1:200, A6397, Invitrogen, Eugene, Oregon, USA) and guinea pig
antiserum against MOR (1:1000, GP10106, Neuromics, Edina,
Minnesota, USA) in the antibody dilution medium for 72 h at
4◦C. The medium consisted of 0.01 M PBS (pH 7.4) containing
5% (v/v) normal donkey serum (PBS-NDS), 0.3% (v/v) Triton
X-100, 0.05% (w/v) NaN3 and 0.25% (w/v) carrageenan. (2) The
sections were then incubated with a mixture of Alexa594-donkey
anti-rabbit IgG (1:500, A21207, Invitrogen, Eugene, Oregon,
USA) and Alexa647-goat anti-guinea pig IgG (1:500, A21450,
Invitrogen, Eugene, Oregon, USA) in PBS-NDS for 4 h at
room temperature. (3) Finally, the sections were incubated
with fluorescein isothiocyanate (FITC)-labeled avidin (1:1000, A-
2001, Vector, Burlingame, CA, USA) in PBS for 2 h at room
temperature. After each step, the slices were washed three times
with 0.01 M PBS. The slices were mounted, cover-slipped and
examined using a confocal laser-scanning microscope (Olympus
FV1000, Tokyo, Japan).
Drugs and Chemicals
6-Cyano-7-nitroquinoxaline-2, 3-dione (CNQX), DL-2-amino-
5-phosphonopentanoic acid (AP-5) and picrotoxin were
purchased from Abcam (Cambridge, MA, USA). D-Phe-Cys-
Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP), 4-aminopyridine
(4-AP), BaCl2 Endomorphin-2 (EM-2), guanosine 5′-[β-
thio]diphosphate trilithium salt (GDP-β-S) and strychnine
were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Tetrodotoxin (TTX) was purchased from Tocris (Tocris
Bioscience, Bristol, UK). All drugs were prepared as stock
solutions according to the manufacturer’s instructions and
were stored frozen at −20◦C. Before each experiment, the drug
stock solutions were added to the normal-aCSF solution to
obtain the experimental concentrations. The time required to
completely exchange the solution in the recording chamber was
2 min. The drugs were applied by switching the bath chamber to
another perfusion solution without changing the perfusion rate
or temperature.
Statistical Analysis
All numerical data are expressed as the means ± the SD. For
the electrophysiology data, n refers to the number of neurons
studied. The concentration–response relationships for multiple
neurons were determined using Prism 5.0 (GraphPad, San Diego,
CA, USA). Where appropriate, group means were compared
using paired t-tests for paired data. Drugs were bath-applied for 8
min. The cumulative probabilities of the inter-event intervals and
the amplitudes of the sEPSCs and mEPSCs were compared using
Kolmogorov–Smirnov tests using the 3 min duration before drug
application as the control amplitude or frequency for comparison
with the amplitudes or frequencies of 3 min duration after 5
min of drug application. Differences between the means were
considered significant at P < 0.05.
Results
Identification of the PPNs
Consistent with previous reports (Nadelhaft and Booth, 1984),
PPNs labeled with TMRwere found in lumbosacral segments L6-
S1 of the rat (Figure 1A1).We performed whole-cell patch-clamp
recordings from PPNs that were retrogradely labeled with TMR
(Figures 1A1,A2). Biocytin was introduced into the intracellular
solution to visualize the recorded PPNs (Figures 1B1,C1,D1)
which were labeled with TMR (Figures 1B2,B3,C2,C3,D2,D4).
These results further confirm that the recorded neurons
were PPNs.
EM-2 Decreases both the Frequency
and the Amplitude of sEPSCs and mEPSCs
via MOR in PPNs
The spontaneous excitatory postsynaptic currents (sEPSCs)
and miniature excitatory postsynaptic currents (mEPSCs) were
recorded under whole-cell voltage clamping at −70 mV, and
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FIGURE 1 | Identification of PPNs and of the recorded PPNs that
were immunostained for MOR. (A1) sacral parasympathetic nucleus
(SPN) located in the mediolateral border of the gray matter that was
identified under a lower magnification with fluorescent illumination.
(A2) tetramethylrhodamine-dextran (TMR)-labeled PPNs were identified
at a higher magnification with fluorescent illumination. (A3) The neuron
shown in (A2), but viewed with infrared illumination during whole-cell
recording. (B1,C1,D1) The recorded neuron shown in (A2,A3), filled with
biocytin and visualized with FITC-conjugate avidin (green) at various
magnifications. (B2,C2,D2) The same section shows TMR
immunoreactivity (Alexa 594) and is shown at the same magnification as
in (B1,C1,D1), respectively. (B3,C3,D4) Merged images show that the
biocytin-filled neuron was the TMR-containing neuron. (D3) The neuron
also shows MOR-Immunoreactive (IR) (Alexa 647). (D4) Merged image
shows that the biocytin-filled neuron was the TMR-containing neuron that
exhibited MOR-IR. Scale bars: 7 µm in (B); 20 µm in (C); 100 µm in (D).
high-pass and low-pass filters were selected to eliminate the
baseline fluctuations and noise. To examine the effects of EM-
2 on the sEPSCs and mEPSCs of the PPNs, 100 µM picrotoxin
and 2 µM strychnine were applied to eliminate the influence of
inhibitory neurotransmission. At the end of the experiments, the
sEPSCs and mEPSCs were blocked by bath application of the
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10 µM α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) receptor antagonist 6-cyano-7-nitroquinoxaline-2, 3-
dione (CNQX), which confirmed that the sEPSCs and mEPSCs
were glutamate-mediated postsynaptic current (n = 7 and n = 3,
respectively, data not shown).
EM-2 Decreased the Amplitudes and Frequencies
of sEPSCs
The effects of EM-2 on sEPSCs were studied in 28 PPNs.
In 23 of 28 tested PPNs, perfusion of EM-2 (3 µM) for 8
min resulted in a reversible reduction in amplitude of sEPSCs
(Figures 2A,B). The remaining 5 PPNs showed a nonsignificant
change in sEPSC amplitude. Overall sEPSC amplitude was
reduced from –17.1 ± 3.9 pA in controls to –13.8 ± 3.2
pA with EM-2 (82 ± 12.5% of the control sEPSC amplitude,
P < 0.01; paired t-test n = 28; Figure 2C). The sEPSC
frequency was also significantly reduced in 25 of 28 tested
PPNs (Figures 2A,B), increased in 1 of 28 tested PPNs, and
unchanged in the remaining 2 PPNs. Overall, sEPSC frequency
was reduced from 1.68 ± 0.85 Hz in the control to 0.87 ± 0.44
Hz with EM-2 (56 ± 24.5% of the control sEPSC frequency;
P < 0.01; paired t-test, n = 28; Figure 2C).
CTOP Blocked the Action of EM-2 on sEPSCs
Figures 3A,B show a recorded PPN that was sensitive to
amplitude- and frequency-decreasing effects of EM-2, and these
effects were abolished in the presence of the selective MOR
antagonist D-Phe-CTOP (CTOP, 1 µM). We examined four
PPNs in which the sEPSC amplitudes and frequencies were
reduced by EM-2 (80.5 ± 2.3% of the control sEPSC amplitude
and 52.8 ± 5.6% of the control sEPSC frequency, P < 0.01;
paired t-test; n = 4; Figure 3C). After 10 min of washout
of the EM-2, the amplitudes and frequencies returned to the
control levels (99 ± 1.2% of the control sEPSC amplitude
and 101 ± 2.5% of the control sEPSC frequency; n = 4; P
> 0.05). Bath application of CTOP (1 µM) had no effect on
the amplitudes or frequencies of the sEPSCs (98 ± 3.5% of
the control sEPSC amplitude and 99 ± 4% of the control
sEPSC frequency; n = 4; P > 0.05), and perfusion with EM-
2 after pretreatment with CTOP had no effect on the sEPSC
amplitudes and frequencies (98.5 ± 2.8% of the control sEPSC
amplitude and 98.5 ± 4.6% of the control sEPSC frequency;
n = 4; P > 0.05; Figure 3C).
Effect of TTX on the EPSCs
In the presence of the Na+-channel blocker tetrodotoxin (TTX,
1 µM), the recorded events at a voltage-clamped −70 mV were
action potential-independent miniature EPSCs (mEPSCs). These
responses are thought to reflect the quantal release of glutamate
acting at non-NMDA receptors (Nicola and Malenka, 1997). In
this study, the recorded EPSC absence of TTX named sEPSC, in
the presence of TTX named mEPSC.
For all eight of the tested PPNs, the average amplitude and
frequency of sEPSCs were −16.5 ± 6.3 pA and 2.01 ± 0.5
Hz, respectively. In eight of eight PPNs, the perfusion of TTX
(1 µM) did not significantly alter the cumulative distribution
of EPSC frequency (P > 0.05). The overall average EPSC
FIGURE 2 | EM-2 decreased amplitudes and frequencies of sEPSCs in
PPNs. (A) Sample traces of sEPSCs in the absence and presence of EM-2. In
this and subsequent figures, the duration of drug superfusion is shown by a
horizontal bar above the chart recording, and 4 consecutive traces of sEPSCs
are shown in the expanded time scales. The period of each trace is 1200 ms.
(B) Cumulative distributions of the amplitudes (left) and inter-event intervals
(right) of the sEPSC before (black line) and during (red line) the EM-2
applications. EM-2 significantly shifted the mean cumulative distribution of the
sEPSC amplitude to lower amplitudes (P < 0.01; Kolmogorov–Smirnov test)
and significantly shifted the mean cumulative distribution of the sEPSC
inter-event intervals to longer durations (P < 0.01; Kolmogorov–Smirnov test).
The data were obtained from the same neuron as in panel (A). (C) Histogram
showing that the sEPSC amplitude and frequency were significantly reduced
by EM-2 (P < 0.01, paired t-test n = 28). In this and the following figures, the
numbers of neurons used to construct each data point are shown in
parentheses. The vertical bars show the SDs. **P < 0.01 vs. control. Holding
potential = −70 mV.
frequency did not significantly change due to perfusion with
TTX (98.5 ± 3.6% of the control sEPSCs frequency; P > 0.05;
paired t-test, n = 8; Figure 4). In six of the eight PPNs, the
amplitudes of the sEPSCs and the mEPSC were not significantly
different (p > 0.05). In the two of eight PPNs that showed
unusually large sEPSC amplitudes, the cumulative distribution
of the EPSC amplitudes was significantly altered (P < 0.05;
Kolmogorov–Smirnov test). However, the overall average EPSC
amplitude did not significantly change due to perfusion with
TTX (96± 3.8% of the control sEPSC amplitude; P> 0.05; n = 8;
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FIGURE 3 | Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-Nh2 (CTOP) blocked the
action of EM-2 on sEPSCs in PPNs. (A) A sample trace of sEPSCs in the
absence and presence of EM-2 (3 µM) together with CTOP (1 µM).
(B) Cumulative distributions of the amplitudes (left) and inter-event intervals
(right) of the sEPSCs in the presence of CTOP (black line) and EM-2 together
with CTOP (red line). EM-2 did not significantly shift the mean cumulative
distribution of the sEPSC amplitude or the inter-event intervals (P > 0.05;
Kolmogorov–Smirnov test). These data were obtained from the same neuron
as in panel (A). (C) Bar graph show the analytical results of four continuous
recordings during which different treatments were performed in four PPNs.
EM-2 clearly decreased the amplitudes and frequency of sEPSCs in these 4
PPNs (P < 0.01). After the washout of EM-2, the amplitudes and frequency
returned to control levels. CTOP had no effect on either the amplitudes or
frequency of sEPSCs (P > 0.05). However, with perfusion of both CTOP and
EM-2, EM-2 was unable to decrease the amplitudes or frequency of the
sEPSCs (P > 0.05). **P < 0.01 vs. control. Holding potential = −70 mV.
Figure 4). Comparison of the amplitudes between sEPSCs and
mEPSCs revealed that TTX selectively eliminated the EPSCs with
relatively large amplitudes, which were thought to be induced by
action potential-dependent transmitter release.
EM-2 Decreased mEPSC Frequency and Amplitude
The effects of EM-2 on mEPSCs were studied in eight PPNs. In
five of eight tested PPNs, perfusion of EM-2 (3 µM) resulted in
FIGURE 4 | Effects of TTX on EPSC frequency and amplitude. Bar graph
showing the effects of TTX (1 µM) on amplitudes and frequencies of EPSCs
relative to control values. Perfusion with TTX did not significantly alter the
average frequency and amplitude of EPSCs (P > 0.05; n = 8).
a reversible reduction in amplitude of mEPSCs (Figure 5A). The
remaining three PPNs showed no significant changes in mEPSC
amplitude. Overall mEPSC amplitude was reduced from –15.7
± 5.2 pA in control to –13.5 ± 4.5 pA with EM-2 (86.4 ± 9.2%
of the control mEPSC amplitude, P < 0.05; paired t-test n =
8; Figure 5A). The frequency of mEPSCs was also significantly
reduced in seven of eight tested PPNs, with frequency being
increased in the remaining one PPN. Overall mEPSC frequency
was reduced from 1.98 ± 0.5 Hz in control to 1.09 ± 0.57 Hz in
EM-2 (53.5 ± 18.9% of the control mEPSC frequency; P < 0.01;
paired t-test, n = 8; Figure 5A).
CTOP Blocked the Action of EM-2 on mEPSCs
We further examined three PPNs in which the amplitude and
frequency of mEPSCs were reduced by EM-2 (82.5 ± 3.6% and
47.2 ± 6.3% of the control mEPSC amplitude and frequency,
respectively; P < 0.01; n = 3; Figure 5B). After 10 min of
washout of EM-2, the amplitudes and frequencies returned to
their control levels, and the bath application of CTOP (1 µM)
had no effect on the amplitude or frequency of the mEPSCs
(101 ± 4.1% of the control mEPSC amplitude and 96 ± 7%
of the control mEPSC frequency; P > 0.05; n = 3). Similarly,
perfusion with EM-2 in the pretreatment with CTOP had no
effect on the mEPSC amplitudes and frequencies (98.2 ± 3.8%
of the control mEPSC amplitude and 97.5 ± 7.1% of the control
mEPSC frequency; P > 0.05; n = 3).
EM-2 Decrease the Excitability of PPNs via
Activation of MORs in the PPNs
EM-2 Hyperpolarized the Resting Membrane
Potentials of the PPNs
These experiments were performed in current-clamp mode with
zero holding current. In the presence of CNQX (10 µM), AP-
5 (100 µM), picrotoxin (100 µM) and strychnine (2 µM)
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FIGURE 5 | EM-2 reduced the mEPSC amplitude and frequency via the
activation of MORs. (A) The effects of EM-2 on the amplitude and frequency
of mEPSCs. Histogram showing that the mEPSC amplitude and frequency were
significantly reduced by EM-2 (P < 0.05 and P < 0.01 respectively; n = 8). (B)
Bar graph showing the analysis of three recordings during which different
treatments were performed in three PPNs. EM-2 clearly decreased the
amplitudes and frequency of sEPSCs in these 3 PPNs (P < 0.01). After the
washout of EM-2, the amplitudes and frequency returned to control levels.
CTOP had no effect on either the amplitudes or frequency of mEPSCs (P >
0.05). However, with perfusion of both CTOP and EM-2, EM-2 was unable to
decrease the amplitudes or frequency of the sEPSCs (P > 0.05). *P < 0.05,
**P < 0.01 vs. control.
to eliminate the influences of excitatory and inhibitory
transmission, the bath application of EM-2 (3 µM) produced a
decrease in resting membrane potential in 11 of the 18 PPNs
(61.1%). The average membrane potential of the 11 positively
responding neurons decreased from−57.8± 6.1 mV to−66.3±
5.3 mV (P < 0.01; n = 11; Figure 6A) combined with a decrease
in input resistance from 483.6 ± 226.5 MΩ to 365.6 ± 186.4
MΩ (P < 0.01; n = 11). Following the washout of EM-2, the
membrane potential returned to its control level, and these
11 PPNs were further investigated. Four of these 11 PPNs
were used to test the effects of TTX (1 µM) on membrane
potentials. TTX alone had no effect on membrane potential
(washout, −58.1 ± 5.3 mV compared with TTX, −58.5 ±
5.5 mV; P > 0.05; n = 4). With TTX + EM-2, the average
membrane potential hyperpolarized to −65.6 ± 5.1 mV from
−58.5 ± 5.5 mV with TTX alone (P < 0.01; n = 4 Figure 6B).
These results indicate that TTX did not affect the EM-2 induced
membrane hyperpolarization. Next, we examined the effect of
CTOP on membrane potentials of another four PPNs. CTOP
(1 µM) itself had no effect on membrane potential (washout,
−56.8 ± 5.3 mV compared with CTOP, −55.6 ± 5.2 mV; P >
0.05; n = 4). However, EM-2 no longer produced membrane
hyperpolarization in the presence of CTOP (CTOP, −55.6 ± 5.2
mV compared with EM-2 + CTOP, −56.3 ± 5.6 mV; P > 0.05;
n = 4; Figure 6C).
Immunostaining for MOR in the above Recorded
Neurons
At the end of the recording, the 18 slices described above were
fixed for further examination of the MOR expression in the
recorded PPNs. Eight of 11 PPNs in which membrane potentials
were hyperpolarized by EM-2 exhibited MOR-IR (Figure 1D3).
The seven PPNs whosemembrane potentials were not responsive
to EM-2 did not exhibit MOR-IR.
Dose-Response Relationship Between EM-2
Concentration and Membrane Hyperpolarization
EM-2-induced membrane hyperpolarization tended to become
more negative with increasing concentrations. Different
concentrations of EM-2 were applied to assess the effect of
a given concentration compared with the control. The dose-
response curve for EM-2 is shown in Figure 6D, and the effective
concentration that produced the half-maximal response (EC50)
was 0.282 µM. EM-2 at 3 µM elicited the maximum effect,
and further increases in the concentration did not increase
the hyperpolarization. Therefore, 3 µM EM-2 was used in
subsequent experiments in the present study.
EM-2 Induced Inwardly Rectifying K+ Currents
through the G-Protein-Coupled Inwardly Rectifying
Potassium (GIRK) Channel, and this Effect was
Mediated by MORs
To examine the types of channels that were involved in the EM-
2-induced membrane hyperpolarization, we compared currents
induced by step voltage pulses in the absence and presence of
EM-2 (Figure 7A). Eight step voltage pulses of 400 ms per
step were applied, ranging from −130 to −50 mV, from the
holding potential of −60 mV. In these experiments the aCSF
solution contained TTX (1 µM), CNQX (10 µM), AP-5 (100
µM), picrotoxin (100 µM) and strychnine (2 µM). Figure 7B
shows that the step voltage pulses induced relative currents in
the absence (black) and presence (red) of EM-2. The net EM-2-
induced current (blue), which was derived from the difference
between the two currents, exhibited a clear reversal and inward
rectification. The measured reversal potential was−95± 2.5 mV
(n = 6), which is close to the value of the equilibrium potential
of K+ (−107 mV) as calculated with the Nernst equation for
our experimental conditions in which the pipette and aCSF
K+ concentrations were 145 mM and 2.5 mM, respectively.
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FIGURE 6 | EM-2 hyperpolarized the RMPs of the PPNs via the
activation of MORs. (A) Histogram showing that the average RMPs of the
11 responsive neurons decreased from −57.8 ± 6.1 mV to −66.3 ± 5.3 mV
in the presence of EM-2 (P < 0.01, paired t-test n = 11). (B) The effect of TTX
on RMPs. Bar graph showing the analysis of four recording during which
different treatments were performed in these four PPNs. The RMPs of PPNs
were hyperpolarized by EM-2 (P < 0.01). After the washout of EM-2, the
RMPs of the recorded PPNs returned to the control levels. TTX alone had no
effect on the membrane potential (P > 0.05; n = 4). TTX did not block the
EM-2-induced membrane hyperpolarization (P < 0.01). (C) CTOP blocked the
action of EM-2 on the RMPs. Bar graph showing the the analysis of four
recording during which different treatments were performed in four PPNs. The
RMPs were hyperpolarized by EM-2 (P < 0.01). After the washout of EM-2,
the membrane potentials of the recorded PPNs returned to control levels.
CTOP itself had no effect on membrane potential (P > 0.05). However, EM-2
did not produce membrane hyperpolarization in the presence of CTOP
(P > 0.05). (D) Dose-response curve of the hyperpolarization of the PPNs by
EM-2. The EC50 value was 0.282 µM. **P < 0.01.
This slight difference might reflect a liquid junction potential
(13.7 mV) between the aCSF and pipette solutions. The EM-2-
induced currents were significantly decreased in the presence of
the potassium channel blocker 4-aminopyridine (4-AP, 1 mM)
(Figure 7C, n = 5) or BaCl2 (1 mM; Figure 7D, n = 4). These
results suggest that EM-2 activated an inwardly rectifying K+
current. After the application of the GDP analog guanosine
5′-[β-thio]diphosphate trilithium salt (GDP-β-S, 2 mM) to the
recording pipette (15–20 min after rupture), EM-2 (3 µM)
evoked no obvious net current (Figure 7E, n = 4), suggesting that
this current involved G-protein-coupled channels. Additionally,
no obvious current was activated by EM-2 (3 µM) in the
presence of CTOP (1 µM; Figure 7F, n = 4), suggesting that
the channel activation induced by EM-2 was mediated by MORs.
FIGURE 7 | Mechanism for EM-2-induced membrane current on PPNs.
(A) Current responses to voltage steps (bottom) in PPNs in the absence
(top) and presence (middle) of EM-2. (B) The current amplitude, which was
measured at the end of the voltage pulses, was plotted against voltages in the
absence (black) and presence (red) of EM-2. The net EM-2-induced current
(blue) was subtracted from the difference between the current responses in the
absence and presence of the EM-2-induced current. (C,D) The average EM-
2-induced current was significantly decreased by perfusion with 4-AP (1 mM,
n = 5) or BaCl2 (1 mM, n = 4). (E) The average EM-2-induced current was
blocked by the addition of GDP-β-S (2 mM) to the pipette solution following
adequate exchange of the pipette solution for 15–20 min (n = 4). (F) Perfusion
with CTOP (1 µM) blocked the average current activation by EM-2 (n = 4).
Taken together, these results suggest that EM-2 induced inwardly
rectifying K+ currents through the G-protein-coupled inwardly
rectifying potassium (GIRK) channel and that this effect was
mediated by MORs.
EM-2 Increased the Rheobase Current and Reduced
the Repetitive Firing of PPNs
The aCSF with 10 µMCNQX, 100 µMAP-5, 100 µMpicrotoxin
and 2 µM strychnine was used to eliminate the influence of
excitatory and inhibitory transmission. Using current-clamp
mode and pulse steps of depolarizing current (steps of 1 pA or 2
pA for 15ms, until action potentials were induced), EM-2 (3µM)
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FIGURE 8 | EM-2 increased the rheobase current and inhibited the
repetitive firing of PPNs. (A) A sample traces showing EM-2 (3 µM)
increased the rheobase current (from 6 pA to 10 pA) and hyperpolarized
the RMPs from −52.8 mV to −60.2 mV (step = 2 pA and duration =
15 ms). (B) EM-2 (3 µM) significantly increased the rheobase current
from a mean of 10.3 ± 2.5 pA to 14.9 ± 2.2 pA (P < 0.01; n = 8). (C) A
sample trace showing that EM-2 (3 µM) decreased the numbers of
spikes in the PPNs in response to progressively depolarizing current
injections with a step size of 5 pA and a 400 ms duration (bottom). EM-2
hyperpolarized the neuron from −58.2 mV to −64.2 mV. (D) The
relationship between the numbers of spikes in PPNs and the amounts of
depolarizing current injected into the neurons. EM-2 reduced repetitive
action potential firing over the entire range of injected currents (5 pA-25
pA) (P < 0.05). However, EM-2 (3 µM) did not significantly reduce the
number of action potentials evoked by larger injected currents (30 pA-35
pA) (P > 0.05). **P < 0.01, *P < 0.05.
significantly increased the rheobase current (the minimum
current required to elicit an action potential; Figure 8A) in 8
of 15 tested PPNs, from a mean of 10.3 ± 2.5 pA to 14.9 ±
2.2 pA (a mean change of 4.6 ± 1.2 pA; P < 0.01; n =
8; Figure 8B). The above 8 PPNs were further examined to
determine the effects of EM-2 on the repetitive firing evoked
by the application of progressively more depolarizing current
injection with steps of 5 pA for 400 ms durations in the current-
clamp mode. Figure 8C shows an example of the effects of EM-2
(3µM), which decreased the number of action potentials of PPNs
in response to progressively depolarizing current injections.
Meanwhile, EM-2 (3µM) hyperpolarized the neuron from−58.2
mV to−64.2 mV. Figure 8D shows that EM-2 reduced repetitive
action potential firing at multiple levels of injected current (5 pA-
25 pA, P < 0.05; n = 8, Figure 8D). This increase in rheobase
current and reduction in repetitive firing was due to a decrease in
the RMPs (from −57.8 ± 6.1 mV to −66.3 ± 5.3 mV; P < 0.05;
n = 8).
Discussion
Previous studies revealed that Endomorphin-1 (EM-1) is widely
and densely distributed throughout the brain and upper
brainstem (Martin-Schild et al., 1999). However, endomorphin-2
(EM-2)-IR varicose fibers were mainly observed in the substantia
gelatinosa of the medulla and the spinal cord dorsal horn
(Martin-Schild et al., 1999; Pierce and Wessendorf, 2000).
Additionally, our recent study revealed that EM-2-IR terminals
form synapses with MOR-expressing PPNs in the rat SPN (Dou
et al., 2013). Therefore, EM-2 was selected for the examination
of the effects of opioids on PPNs in the present study. Previous
studies of the spinal substantia gelatinosa (Yoshimura andNorth,
1983; Schneider et al., 1998), trigeminal substantia gelatinosa
(Grudt and Williams, 1994), spinal ventral horn (Honda et al.,
2012) and locus coeruleus (Williams et al., 1982) have shown
that µ-opioid agonists hyperpolarize the membrane potentials
of these neurons via the activation of K+ channels. Further,
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previous studies have demonstrated that MOR agonists such as
morphine are involved in the inhibition of bladder control (Dray
and Metsch, 1984a,b) and the inhibition of the micturition reflex
at the level of the spinal cord in rat (Hisamitsu and de Groat,
1984). However, patch-clamp recordings examining µ-opioid
modulation of PPNs have not been reported, and little is known
regarding the effects of MOR activation in PPNs. Therefore, in
this study, we examined the cellular effects of EM-2 on PPNs of
the rat SPN.We demonstrated that EM-2 inhibited the excitatory
neurotransmitter release from presynaptic terminals onto PPNs
and hyperpolarized the RMPs of the PPNs, resulting in decreases
in the excitability of the PPNs. We have observed the similar
effects of EM-1 on the PPNs. Merely, the distribution of EM-1
is less than EM-2 in the spinal cord, and the physiological
significant of EM-1 to the bladder function is less important than
EM-2, so we focused on the effects of EM-2 on PPNs in the
present study. The results of the present study could not exclude
the affection of EM-1 on bladder functions, and what is the effect
of EM-1 on bladder function need to be further investigated in
the future.
EM-2 Decreased both the Frequency
and the Amplitude of the PPN sEPSCs
and mEPSCs via MORs
Measurements of the changes in random quantal transmitter
release events are a sensitive means to estimate the locus of
a drug’s effect. Typically, changes in mEPSC amplitudes are
associated with a postsynaptic site of drug action, whereas
changes in mEPSC frequency are likely due to an interaction
with a presynaptic site that changes the probability of
quantal transmitter release (Lupica, 1995). Previous studies
have demonstrated that DAMGO and EM-2 act both pre-
and postsynaptically to alter glutamatergic transmission in the
substantia gelatinosa (Fujita and Kumamoto, 2006) and the
spinal ventral horn (Honda et al., 2012).
Using the application of both picrotoxin and strychnine to
eliminate the influence of inhibitory transmission, the present
results revealed that the spontaneous excitatory postsynaptic
currents (sEPSCs) were completely blocked by the AMPAR
antagonist CNQX, indicating that these sEPSCs were mediated
by glutamatergic AMPA receptors, as reported previously
(Yoshimura and Nishi, 1993). Recordings of glutamatergic
sEPSCs may consist of a mixture of presynaptic action potential-
dependent transmitter release and random quantal transmitter
release (Scanziani et al., 1992). However, in this study, their
frequency and amplitudes were independent of sodium channels,
as shown by blockade with 1 µm tetrodotoxin (TTX), suggesting
that most of the sEPSCs represented genuine mEPSCs. These
results are consistent with those of previous studies of substantia
gelatinosa neurons (Fujita and Kumamoto, 2006; Jiang et al.,
2014) and ventral horn neurons (Honda et al., 2012) in rat spinal
cord slices.
The EM-2-induced decrease in the amplitudes of mEPSCs
was blocked by the application of the selective MOR
antagonist CTOP. These results suggest that the EM-2-induced
inhibitory effect on PPNs was mediated by the activation of
postsynaptic MORs. The EM-2-evoked membrane potential
hyperpolarization might account for the reductions in the
amplitudes of sEPSCs and mEPSCs. Further discussion of EM-2-
induced membrane hyperpolarization of the PPNs is presented
below.
EM-2 also decreased the frequency of mEPSCs, and these
effects were blocked by the application of CTOP. These results
suggest that MORs were expressed on the presynaptic terminals
and that the activation of these MORs decreased glutamate
neurotransmitter release from the presynaptic terminal onto the
PPNs. There is no direct morphological evidence to account for
this functional phenomenon. However, indirect evidence from
our previous studies has demonstrated that MORs are located
in primary afferent neurons containing substance P (SP) or
calcitonin gene-related peptide (Li et al., 1998). Additionally,
our recent study revealed that EM-2, SP and MOR coexist
within the dorsal root ganglion, spinal dorsal horn and primary
afferent fibers and terminals. Moreover, it has been shown that
PPNs send dendrites into the dorsal commissure and into the
lateral funiculus and lateral edge dorsal horn of the spinal cord
(Nadelhaft et al., 1980; Nadelhaft and Booth, 1984; Morgan et al.,
1993), and these regions show heavy immunostaining for MORs
(Ding et al., 1996). These morphological characteristics suggest
that PPNs might form synaptic connections with terminals or
somata of neurons that express MORs and that EM-2 may
interact with presynaptic MORs, resulting in inhibition of
excitatory neurotransmitter release from presynaptic terminals
onto postsynaptic membrane of PPNs (Kohno et al., 1999; Fujita
and Kumamoto, 2006).
The cellular mechanism underlying the presynaptic effects
of EM-2 on PPNs was not examined in this study. Because
previous studies have demonstrated that endomorphins inhibit
high-threshold Ca2+ channel currents in rodent NG 108–15
cells overexpressing MOR (Higashida et al., 1998), we speculate
that these effects might be due to an inhibition of the voltage-
gated Ca2+ channels in nerve terminals. Whether EM-2 affects
GABA or glycine neurotransmission onto PPNs requires further
investigation.
In the present study, we observed a few recorded neurons
that exhibited enhancements in EPSCs in response to perfusion
of EM-2. Although we had added picrotoxin and strychnine
to block the inhibitory neurotransmission mediated by GABAA
receptors and glycine receptors, because we did not use a
GABAB receptor antagonist, this response may be mediated by
GABAB receptors. It has been reported both GABAA andGABAB
receptors are responsible for regulating the activity of PPNs
(Nanninga et al., 1989; Araki, 1994). Presynaptic disinhibition
of inhibitory interneurons may account for this phenomenon, as
reported previously (Vaughan et al., 1997; Morgan and Clayton,
2005; Lau and Vaughan, 2014).
EM-2 Hyperpolarized Resting Membrane
Potential of PPNs via Activation of MOR
Previous studies of the spinal substantia gelatinosa (Yoshimura
and North, 1983; Schneider et al., 1998), trigeminal substantia
gelatinosa (Grudt and Williams, 1994), spinal ventral horn
(Honda et al., 2012) and locus coeruleus (Williams et al.,
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1982) have shown that µ-opioid agonists exert their inhibitory
effects via hyperpolarization of postsynaptic neurons that are
sensitive to the MOR antagonist. Consistent with the above-
mentioned inhibitory effects of opioids in other regions of
the CNS, the present study demonstrated that EM-2 directly
inhibited the PPNs. Bath application of EM-2 produced
membrane hyperpolarization in 61.1% of the recorded PPNs.
This percentage is similar to that observed in patch-clamp
studies of spinal lamina IX neurons (Honda et al., 2012).
The EC50 value of 0.282 µM for the activation of MORs
on the postsynaptic membranes of the PPNs is similar to
that reported previously (Fujita and Kumamoto, 2006). EM-2
significantly hyperpolarized PPNs in the presence of a mixture
of the blocking agents CNQX, AP-5, picrotoxin and strychnine,
which was applied to eliminate the influences of excitatory and
inhibitory transmission. Additionally, EM-2-induced membrane
hyperpolarization was not affected by the presence of TTX. These
results indicate a direct effect of EM-2 on PPNs. Moreover, the
EM-2-induced membrane hyperpolarization was antagonized
by the selective MOR antagonist CTOP. Furthermore, 8 of
the 11 recorded PPNs in which the membrane potentials
were hyperpolarized by EM-2 exhibited MOR-IR. These results
confirm that EM-2 hyperpolarized the membrane potentials of
the PPNs via the activation ofMORs on the PPNs. The remaining
3 PPNs were not IR for MOR, which may reflect the sensitivity
of the antibody. These postsynaptic effects of EM-2 on PPNs
are consistent with previous immunohistochemical (Ding et al.,
1996; Moriwaki et al., 1996), autoradiographic (Gouardères et al.,
1991) and in situ hybridization histochemical studies (Mansour
et al., 1994) reporting that MORs are distributed in the SPN
of rat spinal cord. These results further support our recent
morphological evidence that EM-2-IR terminals form synapses
with the MOR-expressing PPNs in the SPN of the rat L6-S1
lumbosacral spinal cord (Dou et al., 2013).
Mechanism of EM-2 Induced Membrane
Hyperpolarization on PPNs
In other regions of the CNS, the selective MOR agonist DAMGO
has been reported to activate GIRK channels (Schneider et al.,
1998; Honda et al., 2012). To explore the mechanism by
which EM-2 induced membrane hyperpolarization in the PPNs
in the L6-S1 lumbosacral spinal cord of the rat, we further
examined whether EM-2 also activated GIRK channels. Our
data demonstrate that EM-2-induced currents were reversed at
a potential that was close to the predicted potassium equilibrium
potential, exhibited a clear reversal and were inwardly rectifying.
Additionally, the EM-2-induced currents were largely blocked
by presence of the potassium channel blockers BaCl2 or 4-AP
in aCSF. These results indicate that EM-2 activated inwardly
rectifying potassium channels. Moreover, the average EM-2-
induced current was blocked by the addition of GDP-β-S to
the pipette solution. These results suggest that the inhibition
of PPNs is dependent on the activation of G-proteins. The
present results indicate that EM-2 activated GIRK channels.
Furthermore, no current was activated by EM-2 in the presence
of CTOP, suggesting that the channel activation by EM-2 was
mediated by MORs. Taken together, these results suggest that
the direct inhibitory postsynaptic effect of EM-2 on PPNs was
mediated by a direct mechanism involving MOR activation
coupled to GIRK channels and the subsequent hyperpolarization
of the membrane potential.
EM-2 Decreased the Excitability of PPNs
EM-2 significantly increased the minimum current required to
elicit an action potential and reduced the repetitive firing of
action potentials, as we reported recently of the similar effect of
EM-1 in the rat ventrolateral periaqueductal gray (Chen et al.,
2015). These effects of EM-2 on the PPNs were combined with a
decrease in the membrane potentials of the PPNs. Additionally,
the threshold for action potential generation was not significantly
altered by the application of EM-2. These results indicate that
the increase in rheobase current and the reduction of repetitive
firing of the PPNs were due to hyperpolarization of the PPNs:
such hyperpolarization moved the membrane potential further
from the threshold for action potential generation. These results
suggest that EM-2 directly decreased the excitability of the PPNs
via the hyperpolarization of the membrane potentials of PPNs,
which in turn resulted in an increase in the rheobase currents of
PPNs and affected PPN function.
Micturition is a complex behavior involving cortical
(Nadelhaft and Vera, 1995, 2001; Griebling, 2012; Nishijima
et al., 2012), subcortical (Blok, 2002), brainstem (de Groat, 2002;
Nishijima et al., 2005; Sugaya et al., 2005), spinal cord (Beckel
and Holstege, 2011a,b) and bladder mechanisms (Birder et al.,
2010; Wang et al., 2010; Birder and Wyndaele, 2013; Birder,
2013). In the spinal cord, neurons involved in the regulation
of micturition are located in the superficial dorsal horn (Buss
and Shefchyk, 2003), the dorsal gray commissure (Ding et al.,
1997), Onuf’s nucleus (Mannen, 2000) and the SPN (De Groat
et al., 1982). The PPNs in the SPN play a critical role in the
processes of the micturition reflex (De Groat, 1975). In the
intact spinal cord of adult animals, micturition is fulfilled
mainly by multisynaptic reflexes that consist of micturition-
related nuclei at the supraspinal cord level (Fowler et al., 2008;
Nambiar and Lucas, 2014; de Groat et al., 2015). However,
in chronically spinalized animals after spinal cord injury at
cervical or thoracic levels, the primary sensory afferents make
direct synaptic connections with the processes of the PPNs
(Yoshimura et al., 2014; de Groat et al., 2015). Our previous
studies using capsaicin treatment or rhizotomy to disrupt the
normal transportation of EM-2 in primary afferents indicated
that the major source of EM-2-IR fibers and terminals in
the spinal cord is the ipsilateral primary afferent fibers (Hui
et al., 2010; Zhu et al., 2011). Additionally, previous studies
have demonstrated that numerous primary afferents from the
bladder project to the SPN (Pascual et al., 1993). Moreover,
our recent study has revealed that EM-2-IR terminals form
synapses with MOR-expressing PPNs in the rat SPN (Dou et al.,
2013). Based on these results, we concluuded that the primary
sensory afferents from the bladder are important contributors
of EM-2-IR terminals onto PPNs in the SPN region (Dou et al.,
2013).
A previous study using cystometry in the bladder has
shown that activation of MORs reduces the contraction of
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the detrusor (Dmitrieva and Berkley, 2002). Additionally,
previous studies have provided compelling evidence that in
the rat spinal cord, inhibition of micturition is mediated by
MORs (Hisamitsu and de Groat, 1984; Kontani and Kawabata,
1988). Moreover, previous studies in an isovolumetric rat
model have demonstrated that bladder contractions may be
inhibited by the exogenous MOR agonist morphine, and
this effect is abolished by the intravenous administration of
the MOR antagonist naloxone (Dray and Metsch, 1984a).
These results provide further evidence that the EM-2 induced
decrease in the excitability of PPNs leads to inhibition of the
excitatory information outflow from PPNs to parasympathetic
postganglionic neurons.
The results of the present study reveal that EM-2
activated pre- and post-synaptic MORs, inhibiting excitatory
neurotransmitter release from the presynaptic terminals and
decreasing the excitability of PPNs due to hyperpolarization of
their membrane potentials, respectively. Based on the results
of the previous work and our present study, we speculate that
information regarding bladder distention travels via afferent
fibers within the pelvic nerve into the lumbosacral spinal cord. In
the SPN, these EM-2-IR fibers form synaptic connections with
MOR-IR PPNs. EM-2 is released from the presynaptic bouton
and binds with MORs in the postsynaptic membrane, resulting
in decreased excitability of PPNs due to hyperpolarization
of their membrane potentials. The released EM-2 may also
bind with presynaptic MORs, resulting in inhibiting excitatory
neurotransmitter release from the presynaptic terminals. Both of
these inhibitory effects of EM-2 on PPNs are mediated by MOR
via pre- and/or post-synaptic mechanisms and contributed to
the reduction of the excitatory information transmitted via the
PPNs to the parasympathetic postganglionic neurons, resulting
in a significant attenuation in the contractions of the rat bladder.
Finally, these effects influence the micturition reflex formed by
the synaptic connections between primary afferent terminals
and PPNs, resulting in urinary retention.
Conclusion
The present results indicate that the inhibitory effects of EM-2
on PPNs are mediated by MORs via pre- and/or postsynaptic
mechanisms and affect PPNs-related functions. On the one hand,
activation of presynaptic MORs by EM-2 caused the inhibition of
excitatory neurotransmitter release from presynaptic terminals,
on the other hand, EM-2 activated postsynaptic MORs and
subsequently hyperpolarized the RMPs of the PPNs, resulting in
decreases in the excitability of the PPNs. Both of these inhibitory
effects of EM-2 contribute to the inhibition of micturition reflex
formed by the synaptic connections between primary afferent
terminals and PPNs. These inhibitory effects of EM-2 on PPNs
at the spinal cord level may explain the mechanism of action of
morphine treatment andmorphine-induced bladder dysfunction
in the clinic.
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